Gamida Cell Ltd. is a biopharmaceutical company focused on developing advanced cellular therapies for the treatment of severe blood cancers and other hematologic diseases. The company generates revenue by bringing its proprietary technologies through clinical development and forming strategic partnerships to commercialize its therapies, potentially impacting patient outcomes and healthcare markets.